Cargando…
Current Strategies to Inhibit High Affinity FcεRI-Mediated Signaling for the Treatment of Allergic Disease
Allergies and asthma are a major cause of chronic disease whose prevalence has been on the rise. Allergic disease including seasonal rhinitis, atopic dermatitis, urticaria, anaphylaxis, and asthma, are associated with activation of tissue-resident mast cells and circulating basophils. Although these...
Autor principal: | Gomez, Gregorio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374298/ https://www.ncbi.nlm.nih.gov/pubmed/30792720 http://dx.doi.org/10.3389/fimmu.2019.00175 |
Ejemplares similares
-
SLAP Is a Negative Regulator of FcεRI Receptor-Mediated Signaling and Allergic Response
por: Sharma, Namit, et al.
Publicado: (2019) -
SG-SP1 Suppresses Mast Cell-Mediated Allergic Inflammation via Inhibition of FcεRI Signaling
por: Kim, Min-Jong, et al.
Publicado: (2020) -
Regulation of Trafficking and Signaling of the High Affinity IgE Receptor by FcεRIβ and the Potential Impact of FcεRIβ Splicing in Allergic Inflammation
por: Arthur, Greer K., et al.
Publicado: (2022) -
An Interaction Library for the FcεRI Signaling Network
por: Chylek, Lily A., et al.
Publicado: (2014) -
Scrodentoid A Inhibits Mast Cell–Mediated Allergic Response by Blocking the Lyn–FcεRIβ Interaction
por: Qian, Fei, et al.
Publicado: (2019)